Analgesic; Antiinflammatory; Antispasmodic; Aromatherapy; Aromatic; Carminative; Diuretic; Emmenagogue; Expectorant; Galactogogue; Hallucinogenic; Stimulant; Stomachic
Brazil; Afghanistan; Madagascar; Italy; Bangladesh; Sudan; Lebanon; Nepal; France; Bahamas; Ethiopia; Rwanda; Tanzania; Somalia; Ireland; Swaziland; Argentina; Thailand; Turkmenistan; Israel; Iran; Algeria; Cuba; Turkey; Jordan; Cape Verde; Russia; United States; Zimbabwe; China; Chile; Belgium; Germany; Dominican Republic; Iraq; Djibouti; Spain; Ukraine; Eritrea; Netherlands; Libya; Pakistan; Philippines; Indonesia; Mauritius; Morocco; Kenya; Switzerland; New Zealand; Poland; Haiti; Bulgaria; Jamaica; Romania; Albania; Angola; Portugal; Mexico; Egypt; Tajikistan; South Africa; India; Peru; United Kingdom; Tunisia; Austria; Mozambique; Colombia; Greece; Hungary; South Korea; Fiji
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials |
---|
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.